Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 149

1.

Screening for prostate cancer: a Cochrane systematic review.

Ilic D, O'Connor D, Green S, Wilt T.

Cancer Causes Control. 2007 Apr;18(3):279-85. Epub 2007 Jan 6. Review.

PMID:
17206534
[PubMed - indexed for MEDLINE]
2.

Screening for prostate cancer.

Ilic D, Neuberger MM, Djulbegovic M, Dahm P.

Cochrane Database Syst Rev. 2013 Jan 31;1:CD004720. doi: 10.1002/14651858.CD004720.pub3. Review.

PMID:
23440794
[PubMed - indexed for MEDLINE]
3.

Screening for prostate cancer.

Ilic D, O'Connor D, Green S, Wilt T.

Cochrane Database Syst Rev. 2006 Jul 19;(3):CD004720. Review. Update in: Cochrane Database Syst Rev. 2013;1:CD004720.

PMID:
16856057
[PubMed - indexed for MEDLINE]
4.

Lycopene for the prevention of prostate cancer.

Ilic D, Forbes KM, Hassed C.

Cochrane Database Syst Rev. 2011 Nov 9;(11):CD008007. doi: 10.1002/14651858.CD008007.pub2. Review.

PMID:
22071840
[PubMed - indexed for MEDLINE]
5.

Effectiveness and safety of vitamin D in relation to bone health.

Cranney A, Horsley T, O'Donnell S, Weiler H, Puil L, Ooi D, Atkinson S, Ward L, Moher D, Hanley D, Fang M, Yazdi F, Garritty C, Sampson M, Barrowman N, Tsertsvadze A, Mamaladze V.

Evid Rep Technol Assess (Full Rep). 2007 Aug;(158):1-235. Review.

PMID:
18088161
[PubMed - indexed for MEDLINE]
Free Article
6.

Systematic review: comparative effectiveness and harms of treatments for clinically localized prostate cancer.

Wilt TJ, MacDonald R, Rutks I, Shamliyan TA, Taylor BC, Kane RL.

Ann Intern Med. 2008 Mar 18;148(6):435-48. Epub 2008 Feb 4. Review. Erratum in: Ann Intern Med. 2008 Jun 3;148(11):888.

PMID:
18252677
[PubMed - indexed for MEDLINE]
7.

Screening for prostate cancer: systematic review and meta-analysis of randomised controlled trials.

Djulbegovic M, Beyth RJ, Neuberger MM, Stoffs TL, Vieweg J, Djulbegovic B, Dahm P.

BMJ. 2010 Sep 14;341:c4543. doi: 10.1136/bmj.c4543. Review.

PMID:
20843937
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.

Shepherd J, Jones J, Frampton GK, Tanajewski L, Turner D, Price A.

Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. Review.

PMID:
18547499
[PubMed - indexed for MEDLINE]
Free Article
9.

Screening for lung cancer: a systematic review and meta-analysis of controlled trials.

Manser RL, Irving LB, Byrnes G, Abramson MJ, Stone CA, Campbell DA.

Thorax. 2003 Sep;58(9):784-9. Review.

PMID:
12947138
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

The role of vitamin E in the prevention of cancer: a meta-analysis of randomized controlled trials.

Alkhenizan A, Hafez K.

Ann Saudi Med. 2007 Nov-Dec;27(6):409-14.

PMID:
18059122
[PubMed - indexed for MEDLINE]
11.

Oral naltrexone as a treatment for relapse prevention in formerly opioid-dependent drug users: a systematic review and economic evaluation.

Adi Y, Juarez-Garcia A, Wang D, Jowett S, Frew E, Day E, Bayliss S, Roberts T, Burls A.

Health Technol Assess. 2007 Feb;11(6):iii-iv, 1-85. Review.

PMID:
17280624
[PubMed - indexed for MEDLINE]
Free Article
12.

[Screening for prostate cancer--what does the evidence show?].

Borre M, Iversen P.

Ugeskr Laeger. 2007 May 14;169(20):1887-8. Review. Danish.

PMID:
17553362
[PubMed - indexed for MEDLINE]
13.

Screening for prostate cancer: an update.

Bryant RJ, Hamdy FC.

Eur Urol. 2008 Jan;53(1):37-44. Epub 2007 Aug 27. Review.

PMID:
17826892
[PubMed - indexed for MEDLINE]
14.

Screening programmes for the early detection and prevention of oral cancer.

Kujan O, Glenny AM, Oliver RJ, Thakker N, Sloan P.

Cochrane Database Syst Rev. 2006 Jul 19;(3):CD004150. Review. Update in: Cochrane Database Syst Rev. 2010;(11):CD004150.

PMID:
16856035
[PubMed - indexed for MEDLINE]
15.

What will the emperor say? Screening for prostate cancer as of 2008.

Concato J.

Cancer J. 2009 Jan-Feb;15(1):7-12. doi: 10.1097/PPO.0b013e31819765da.

PMID:
19197166
[PubMed - indexed for MEDLINE]
16.

Benefits and harms of prostate-specific antigen screening for prostate cancer: an evidence update for the U.S. Preventive Services Task Force.

Lin K, Lipsitz R, Miller T, Janakiraman S; U.S. Preventive Services Task Force.

Ann Intern Med. 2008 Aug 5;149(3):192-9. Review.

PMID:
18678846
[PubMed - indexed for MEDLINE]
17.

Trials of decision aids for prostate cancer screening: a systematic review.

Volk RJ, Hawley ST, Kneuper S, Holden EW, Stroud LA, Cooper CP, Berkowitz JM, Scholl LE, Saraykar SS, Pavlik VN.

Am J Prev Med. 2007 Nov;33(5):428-434. Review.

PMID:
17950409
[PubMed - indexed for MEDLINE]
18.

Systematic review of early vs deferred hormonal treatment of locally advanced prostate cancer: a meta-analysis of randomized controlled trials.

Boustead G, Edwards SJ.

BJU Int. 2007 Jun;99(6):1383-9. Epub 2007 Mar 6. Review. Erratum in: BJU Int. 2007 Jun;99(6):1390.

PMID:
17346269
[PubMed - indexed for MEDLINE]
19.

Health-related quality of life and cost-effectiveness studies in the European randomised study of screening for prostate cancer and the US Prostate, Lung, Colon and Ovary trial.

Miller AB, Madalinska JB, Church T, Crawford D, Essink-Bot ML, Goel V, de Koning HJ, Määttänen L, Pentikäinen T.

Eur J Cancer. 2001 Nov;37(17):2154-60. Review.

PMID:
11677101
[PubMed - indexed for MEDLINE]
20.

Prostate-Specific Antigen-Based Screening for Prostate Cancer: An Evidence Update for the U.S. Preventive Services Task Force [Internet].

Lin K, Croswell JM, Koenig H, Lam C, Maltz A.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2011 Oct.

PMID:
22171385
[PubMed]
Books & Documents

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk